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Background: Oxygen plays a key role in organ 
development, including pancreatic -cells. 
Results: High oxygen condition increases Ngn3-
positive and insulin-positive cells from both 
mouse and human pluripotent stem cells. 
Conclusion: Culturing under high oxygen 
conditions has a facilitative effect on pancreatic 
differentiation. 
Significance: This new method provides an 
efficient method to utilize patient-specific iPS 
cells for the treatment of diabetes. 
 
ABSTRACT 
   Pluripotent stem cells have potential 
applications in regenerative medicine for 
diabetes. Differentiation of stem cells into 
insulin-producing cells has been achieved using 
various protocols. However, both the efficiency 
of the method and potency of differentiated 
cells are insufficient. Oxygen tension, the 
partial pressure of oxygen, has been shown to 
regulate the embryonic development of several 
organs, including pancreatic -cells. In this 
study, we tried to establish an effective method 
for the differentiation of induced pluripotent 
stem cells (iPSCs) into insulin-producing cells 
by culturing under high oxygen (O2) conditions. 
Treatment with a high O2 condition in the early 
stage of differentiation increased insulin-
positive cells at the terminus of differentiation. 
We found that a high O2 condition repressed 
Notch-dependent gene Hes1 expression and 
increased Ngn3 expression at the stage of 
pancreatic progenitors. This effect was caused 
by inhibition of hypoxia-inducible factor-1 
(HIF-1) protein level. Moreover, a high O2 
condition activated Wnt signaling. Optimal 
stage-specific treatment with a high O2 
condition resulted in a significant increase in 
insulin production in both mouse embryonic 
stem cells (mESCs) and human iPSCs (hiPSCs), 
and yielded populations containing up to 10% 
C-peptide-positive cells in hiPSCs. These 
results suggest that culturing in a high O2 
condition at a specific stage is useful for the 
efficient generation of insulin-producing cells. 
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Cell replacement therapy has become possible 
by utilizing artificially generated cells or organs 
from embryonic stem cells (ESCs), induced 
pluripotent stem cells (iPSCs) and adult stem cells. 
These stem cells have marked potential to develop 
into many different cell types in the body during 
early life and growth. Over the last decade, with 
the advent of new techniques and technologies in 
modern molecular biology, understanding of the 
underlying mechanism responsible for organ 
differentiation has developed rapidly. This 
knowledge has given rise to various new methods 
of manipulating stem cells in order to generate 
deficient organs in various diseases. To date, 
various differentiation methods have been 
developed for each cell type, including neurons, 
cardiomyocytes, and pancreatic endocrine cells. 
Many of these methods are based on mimicking 
the in vivo development. The development of 
efficient and safe methods is desired for clinical 
applications and studying the cause of disease. 
Pluripotent stem cells are capable of 
spontaneous differentiation into insulin-producing 
cells. This is mainly carried out by preferential 
differentiation of stem cells into insulin-producing 
cells by changing the composition of the culture 
medium and causing the expression of dominant 
transcription factor genes, which are mainly 
involved in pancreatic development. Several 
groups have reported methods of generating 
pancreatic cell lineages from ESCs and iPSCs (1-
8). These methods induce definitive endoderm 
differentiation in the first stage, then pancreatic 
specialization and maturation in following stages, 
using combinations of growth factors, small 
molecules and extracellular matrix. Lumelsky et 
al. first demonstrated the successful differentiation 
of mouse ESCs (mESCs) to insulin-secreting 
structures, which was concluded to be similar to 
pancreatic islets (6). However, the limiting factor 
of this method is that the abundance of 
differentiated cells is relatively low. Moreover, 
several reports had the same issue that the 
differentiated cells are immature and/or not fully 
functional in culture. Some reports succeeded in 
generating functional insulin-secreting cells 
utilizing differentiation under implantation or co-
culture with organ-matched mesenchyme (7,8). 
However, such methods have a risk of teratoma or 
teratomatous tissue element formation in their 
grafts. Fifteen percent of grafts showed teratoma 
or a teratomatous tissue element (7). To improve 
this issue, establishment of more safe and efficient 
methods is desired. 
Oxygen (O2) plays a crucial role in cellular 
homeostasis (9,10). In normal tissues, the lack of 
oxygen contributes to cell death, while in stem 
cells, lack of O2 controls stem cell self-renewal 
and pluripotency by activating specific signaling 
pathways such as Notch and the expression of 
transcriptional factors such as Oct4 (11,12). 
Hypoxia is accompanied by the stabilization of 
hypoxia-inducible factors (HIFs), O2-regulated 
transcriptional factors regulate an ever-increasing 
number of genes involved in glycolytic 
metabolism, angiogenesis, erythropoiesis, and 
metastasis, and mediate the adaptation of cells to 
decreased O2 availability (13,14). O2 tension, the 
partial pressure of O2, has been shown to regulate 
the embryonic development of several organs, 
including the trachea, heart, lung, limb bud, and 
bone (15-19). It is also reported that O2 tension 
plays a key role in pancreatic development (20-
23). The embryonic pancreas early in 
development is poorly vascularized and has a 
paucity of blood flow and, at later stages, blood 
flow increases and endocrine differentiation 
occurs at the same time (21). It is also shown that 
HIF-1 protein is highly expressed in the 
embryonic pancreas early in development, and 
that increasing concentrations of O2 in vitro 
repressed HIF-1 expression and fostered the 
development of endocrine progenitors (22,23). 
Suitable O2 concentrations should be tested for the 
differentiation efficiency of ESC and iPSC into 
pancreatic lineages. However, until now, there has 
been no report of such an effect on ESC and iPSC 
differentiation in vitro. 
Here we studied the effect of increasing 
concentrations of O2 on the differentiation 
efficiency of mESC and human iPSC (hiPSC) into 
pancreatic lineages. A high O2 condition (60% O2) 
in early stages of differentiation increased the 
percentage of Ngn3-expressing endocrine 
progenitors and insulin-positive cells in both 
mESC and hiPSC. This effect was mediated via 
the inhibition of HIF-1 expression and increase 
of Ngn3 gene expression. Moreover, a high O2 
condition was found to induce the activation of 
Wnt signaling. In this study, we demonstrated that 
culturing ESC and iPSC in a high O2 condition 
improved differentiation efficiency into endocrine 
High oxygen facilitates pancreatic differentiation 
 3 
progenitors and insulin-producing cells compared 
with normoxic conditions. 
 
EXPERIMENTAL PROCEDURES 
mESC and hiPSC lines - The mESC line 
ING112, containing an Ins1-promoter-driven GFP 
reporter transgene, was established by culturing 
blastocysts obtained from transgenic mice 
homozygous for the Ins1-GFP gene (3,24). 
ING112 cells were maintained on mouse 
embryonic fibroblast (MEF) feeders in high 
glucose Dulbecco’s modified Eagle’s medium 
(DMEM) (Invitrogen, Carlsbad, CA, USA) 
supplemented with 1,000 units/ml leukemia 
inhibitory factor (LIF; Wako, Osaka, Japan), 10% 
fetal bovine serum (FBS; HyClone Laboratories, 
Losan, UT, USA), 100 µM nonessential amino 
acids (NEAA), 2 mM L-glutamine (L-Gln), 1 mM 
sodium pyruvate, 50 units/ml penicillin and 50 
µg/ml streptomycin (P/S), and 100 µM -
mercaptoethanol (-ME). The hiPSC clone 23 
(C23) was previously produced by Sendai virus 
vector expressing OCT3/4, SOX2, KLF4, and c-
MYC (25). C23 cells were maintained on 
mitomycin C (mmc; Nacalai Tesque, Kyoto, 
Japan)-treated MEF feeders in DMEM/F12 HAM 
(Sigma, St. Louis, MO, USA) supplemented with 
100 µM NEAA, 2 mM L-Gln, 20% Knockout 
Serum Replacement (KSR; Invitrogen), 25 
units/ml penicillin and 25 µg/ml streptomycin, 
100 µM -ME, and 5 ng/ml bFGF (Peprotech, 
Rocky Hill, NJ, USA).  
Differentiation of mESC and hiPSC into 
insulin-producing cells - Prior to differentiation, 
mESCs were passaged using 0.25% trypsin and 
seeded at 35000 cells per well on 4-well or 24-
well plates coated with 50 µg/ml poly-L-lysine 
(Sigma) and 2.5 µg/well laminin (Roche Applied 
Science, Indianapolis, IN, USA). After overnight 
culture, the cells were cultured in high-glucose 
(4500 mg/l) DMEM supplemented with 10 mg/l 
insulin, 5.5 mg/l transferrin, 6.7 µg/ml sodium 
selenite (Insulin-Transferrin-Selenium-G 
Supplement, ITS; Invitrogen), 2.5 mg/ml 
ALBUMAX II (Invitrogen), NEAA, L-Gln, P/S, 
β-ME, 10 ng/ml activin A (Act A; R&D Systems, 
Minneapolis, MN, USA), and 5 ng/ml bFGF 
(Peprotech) from day 1 to day 6. From day 7 to 10, 
the culture medium was changed to RPMI 
supplemented with NEAA, L-Gln, P/S, -ME, 
B27 supplement (Invitrogen), 50 ng/ml FGF10 
(Peprotech), 250 nM KAAD-cyclopamine (CYC; 
Calbiochem, San Diego, CA, USA), and 1 µM 
retinoic acid (RA; Sigma). At day 11, the medium 
was switched to low-glucose (1000 mg/l) DMEM 
supplemented with ITS, ALBUMAX II, NEAA, 
L-Gln, PS, -ME, 10 mM nicotinamide (NAM; 
Sigma), and 10 nM glucagon-like peptide (GLP1; 
Sigma), and the cells were cultured until day 17. 
hiPSCs were passaged as small clusters using 1 
U/ml dispase (Roche Applied Science) at a 1:5 
split ratio weekly and plated on mmc-treated MEF 
feeders of 4-well or 24-well plates. After one 
week culture, the cells were cultured in 
differentiation medium in the same way as mouse 
ESCs. 
Cells were cultured under high O2 
concentration conditions (60% O2) for the 
indicated periods in a multi-gas incubator (APM-
30DR; ASTEC, Fukuoka, Japan). 
Immunostaining - Cells were washed with 
phosphate-buffered saline (PBS) and fixed in 4% 
paraformaldehyde for 30 min at room temperature 
(22-24ºC). Immunostaining was carried out with 
the standard protocol. The following primary 
antibodies were used: mouse anti-GFP (1:1000; 
Medical and Biological Laboratories, Nagoya, 
Japan), goat anti-Sox17 (1:200; R&D Systems), 
anti-Pdx1 (1:1000; Upstate Biotechnology, Lake 
Placid, NY, USA), anti-Ngn3 (1:100; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), goat anti-
Foxa2 (1:300; Santa Cruz Biotechnology), mouse 
anti-Insulin (1:1000; Sigma), and rabbit anti-C-
Peptide (Cell Signaling Technology, Beverly, MA, 
USA). Alexa488 or Alexa568-conjugated 
secondary antibodies were used at 1:500 dilution 
(Molecular Probe, Eugene, OR, USA). Cells were 
counterstained with DAPI (Roche Applied 
Science). Images were taken with an Olympus 
IX81 fluorescence microscope (Olympus Optical 
Co Ltd, Tokyo, Japan). Quantification was carried 
out using MetaMorph software (Molecular 
Devices). After images of marker fluorescence 
and DAPI fluorescence were taken in defined 
areas of wells in the cell culture plate, each image 
was thresholded to exclude background noise. The 
area was quantified and the percentage of marker-
positive cells was calculated by dividing the 
DAPI-positive area (total cell number) into the 
marker-positive area (supplementary Fig. S1). 
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Quantitative real-time PCR - Total RNA was 
isolated from cells using a Trizol reagent 
(Invitrogen) according to the manufacturer’s 
instructions. cDNA was synthesized using a 
Superscript III First-Strand Synthesis System 
(Invitrogen) according to the manufacturer’s 
instructions. Quantitative real-time PCR (qPCR) 
analysis was performed on an ABI Prism 7300 
(Applied Biosystems, Foster City, CA, USA) 
using a SYBR Premix ExTaq GC (Takara, Shiga, 
Japan). The primer sequences for each primer set 
are shown in Table 1. mRNA expression data were 
normalized against Actin expression in a 
corresponding sample. The data were analyzed 
using the relative Quantification (rQ) study in 
Sequence Detection Software V. 1.2 (Applied 
Biosystems). 
Immunoblotting - HIF-1 levels were 
determined using immunoblotting. Cells were 
washed with PBS, scraped and lysed in RIPA 
buffer (50 mΜ Tris-HCl, pH 7.5, 4 mM EGTA, 
150 mM NaCl, 50 mM NaF, 1 mM Na3VO4, 30 
mM Na4P2O7-10H2O, 10 mM EDTA, 1% Triton 
X-100). After sonication, the insoluble materials 
were removed by centrifugation at 15,000 rpm for 
15 min. The supernatants were then mixed with a 
5-fold amount of Laemmli’s sample buffer (0.38 
M Tris-HCl, pH 6.8, 12% SDS, 30% β -
mercaptoethanol, 10% glycerol, 0.05% 
bromophenol blue) and boiled for 4 min. Samples 
were loaded and subjected to SDS-PAGE and then 
transferred to a nitrocellulose membrane (Bio-Rad 
Laboratories, Hercules, CA, USA), and then 
blocked for nonspecific binding in a 5% skim 
milk solution. Membranes were incubated with 
mouse anti-HIF-1 antibody (1:1000; R&D 
Systems) or mouse anti--actin (1:1000; 
Chemicon, Temecula, CA, USA) overnight at 4ºC. 
Then membranes were washed and incubated for 
1 h with HRP-conjugated goat anti-mouse IgG 
antibody (1:2000; Dako, Carpinteria, CA, USA). 
After washing, membranes were incubated with 
enhanced chemiluminesce reagent (GE Healthcare, 
Piscataway, NJ, USA) and the immunoreactive 
proteins were visualized by a ImageQuart400 
(GE). 
MicroArray - Microarray analysis was 
performed on total RNA samples using TORAY 
3D-gene oligo chip (TORAY, Tokyo, Japan), 
according to the manufacturer’s instructions. The 
genes induced by a high O2 environment were 
determined by global normalization after 
excluding genes of <100 intensity in the high O2 
condition-treated group. Genes increased over 8-
fold in the ratio of high O2 condition to normoxia 
are listed in Fig. 6A. Pathway analysis was 
performed on upregulated genes in the high O2 
condition-treated or echinomycin-treated group 
using GenMapp/MAPP Finder software. 
Statistics - Data are shown as the mean ± 
S.E.M. Student's t-test was used to identify 
significant differences between two conditions 
and one-way ANOVA or  two-way ANOVA 
followed by Tukey-Kramer’s post-hoc analysis 
was used to compare multiple
 
conditions. P < 0.05 
was considered to be significant. 
 
RESULTS 
High oxygen condition facilitates the 
differentiation of mESC into insulin-producing 
cells - We used a modified protocol from a 
previous report of three-stage stepwise 
differentiation into insulin-producing cells (25,26) 
(Fig. 1A). First, mESC ING112 cells were treated 
with ActA and bFGF to direct the differentiation 
into definitive endoderm from day 1 to day 7. By 
day 7, there was a steep reduction in the 
expression of Oct4 relating to the fact that the 
cells have transitioned from pluripotency to an 
endodermal progenitor (Fig. 1B). This is evident 
from the increased expression of Sox17 and Foxa2 
on day 7, both of which are markers of a 
definitive endoderm. With the change in the 
composition of the medium containing B27, 
FGF10, CYC, and RA from day 7 onwards, there 
was a gradual decrease in the expression of Sox17 
and Foxa2. Subsequently, there was a marked 
increase in the expression of Pdx1 and Ngn3 on 
day 11, indicating the prevalence of pancreatic 
progenitors and endocrine progenitors in the 
population of the culture. With the change in the 
medium composition containing NAM and GLP-1 
on day 11, Pdx1 and Ngn3 expressions decreased 
while the maximum level of Ins1 expression was 
reached. 
Next we examined the effects of a high O2 
concentration condition on the differentiation 
efficiency of mESC ING112 cells. We cultured 
cells in a high O2 condition (60% O2) under 
stepwise differentiation during stage 1 (day 3-7), 
stage 2 (day 7-11), or stage 3 (day 11-17) (Fig. 
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2A). It was observed that a high O2 condition 
during stage 1, the early phase of differentiation, 
had the greatest effect on differentiation efficiency 
with an almost 8-fold increase (P <0.05) in the 
percentage of Ins1-GFP-positive cells (Fig. 2, B 
and C). However, a high O2 condition during 
stage 2 or stage 3 had no effect on differentiation 
efficiency. At the beginning of these experiments, 
we cultured under high O2 conditions from day 1; 
however, earlier treatment had a deleterious effect 
on the percentage of surviving cells (Fig. 2F). 
Therefore, we used this protocol as the high O2 
condition from day 3. To determine whether 60% 
high O2 is the best condition, we tested different 
levels of O2 condition. As a result, 40% O2 during 
stage 1 also increased the percentage of Ins1-
GFP-positive cells by 4-fold (P <0.05; Fig. 2G), 
but this effect was less than that of 60% O2. 
Instead of high O2, we used a hypoxic condition 
during differentiation, but there was no change 
compared with the normoxic condition (Fig. 2D). 
The high O2 condition also increased the 
percentage of C-peptide-positive cells in a 
different mESC line, SK7 (27,28) (Fig. 2E). 
High oxygen condition facilitates 
differentiation into endocrine progenitors - Based 
on the results in Figure 2B and C, we compared 
gene expression levels between the normoxia and 
high O2 condition groups on day 6 of stage 1 (Fig. 
3A). We observed a significant decrease (P 
<0.0005) in the expression of Oct4, which is 
indicative of the fact that the cells lost their 
pluripotency (Fig. 3B). Whereas there was no 
difference in the expression of Sox17, a marker 
gene of definitive endoderm, there was an almost 
6-fold (p<0.005) and 7-fold increase (P <0.0005) 
in the expressions of Pdx1 and Ngn3, respectively 
(Fig. 3B). To determine the proportion of cells 
expressing each marker, immunofluorescence 
analysis was performed. There was no marked 
difference in the number of Sox17-positive cells 
on day 6 (Fig. 3C), and Pdx1-positive cells on day 
11 (Fig. 3D), although induction of its gene 
expression was observed (Fig. 3B). It was 
confirmed that the number of Ngn3-positive cells 
was significantly increased on day 11 (Fig. 3E). 
Quantification of the percentage of Ngn3-positive 
cells showed an almost 3-fold (P <0.0005) 
increase (Fig. 3F). These results show that the 
high O2 condition reduced the pluripotency of the 
cells and directed them markedly towards 
endocrine progenitors. 
In our differentiation protocol, stage 1 
contained supplements such as Activin A (ActA) 
and bFGF in the medium to direct toward a 
definitive endoderm. Next, to clarify which high 
O2 condition affected undifferentiated mESC or 
differentiating cells, we examined the effect of a 
high O2 condition on Ngn3 expression in 
undifferentiated cells. Treatment with a high O2 
condition for 3 days did not affect Ngn3 
expression in the undifferentiated state maintained 
in mESC medium compared to treatment in 
differentiation medium, showing that the high O2 
condition affected differentiating cells  (Fig. 3G). 
High oxygen condition represses HIF-1 
protein level and Hes1 gene expression - Even 
under normoxia, HIF-1 is reported to be 
expressed at a detectable level and participate in 
the expression of hypoxia-inducible genes in 
mESCs (29). Therefore, we compared HIF-1 
protein level and its target gene expression 
between normoxic and high O2 condition groups. 
High O2 condition during day 3 to day 6 of 
differentiation repressed HIF-1 protein level (Fig. 
4, A and B). Under normoxic conditions, Vegfa 
expression, a HIF-1 targeting gene, increased 
from day 4 with a peak level on day 5 of 
differentiation, showing that activation of HIF-1 
occurs during differentiation, while the high O2 
condition significantly decreased Vegfa expression 
on day 5 and 6 (P <0.05, respectively; Fig. 4C). It 
is reported that HIF-1 activates Notch signaling 
in stem cells and embryonic pancreatic cells 
(11,22). Hypoxia and subsequent HIF-1 
expression induced hairy and enhancer of split 
(Hes) 1 expression, Notch downstream gene, and 
repressed Ngn3 expression, leading to the 
inhibition of -cell development (22). Therefore, 
we compared the kinetics of Hes1 and Ngn3 
expression in normoxia with those in the high O2 
condition. Under differentiation, Hes1 expression 
was slightly increased at d4, and gradually 
decreased from day 5, while high O2 condition 
significantly repressed its expression on day 5 and 
6 (P <0.01 and P <0.05, respectively; Fig. 4D). In 
contrast, Ngn3 expression significantly increased 
on both day 5 and 6 in the high O2 condition (P 
<0.05, respectively; Fig. 4E).  
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Next we examined the effect of HIF-1 
inhibition on Ngn3 expression under 
differentiation. Cells were treated with 1 nM 
echinomycin, an inhibitor of HIF-1 from day 3 
to 6. On day 6, Ngn3 expression was significantly 
increased by echinomycin treatment, while Vegfa 
and Hes1 expressions were decreased (P <0.0005, 
P <0.05 and p<0.05, respectively; Fig. 4F). These 
expression profiles were similar to those in the 
high O2 condition. Hence, it was shown that HIF-
1 inhibition and subsequent repression of Notch 
signaling play a role in facilitated differentiation 
in the high O2 condition. 
High oxygen condition activates Wnt signaling 
pathway – To further clarify the effect of the high 
O2 condition on differentiating cells, we 
performed microarray analysis on normoxia or 
high O2-treated cells. As a result, many genes 
were upregulated by the high O2 condition, and 
genes showing over 8-fold expression in the high 
O2 group compared to the normoxia group are 
listed in Figure 5A. Pathway analysis using 
upregulated genes in the high O2 group indicated 
that several genes were involved in the Wnt 
signaling pathway, and this pathway was ranked 
first (P <0.01; Fig. 5B). Wnt3, Wnt6 (over 8-fold), 
Wnt5a, Wnt10a (over 4-fold; data not shown), 
Wnt4, Wnt7b, Wnt10b, Fzd1, Myc and Ccnd2 
(over 2-fold; data not shown) were increased in 
the high O2 group and detected as the Wnt 
signaling pathway. We also performed microarray 
analysis on the echinomycin-treated group. 
Similarly, the Wnt signaling pathway was ranked 
first when analyzed using upregulated genes (P 
<0.001; Fig. 5C), suggesting that HIF-1 
inhibition led to the activation of Wnt signaling. 
The Wnt/beta-catenin pathway plays an 
important role in the regulation of pluripotency 
and pancreatic development and differentiation 
(1,30-32). Hence, we examined the effect of Wnt 
inhibitor Dkk-1 on high O2-induced Ngn3 
expression. The application of Dkk-1 led to 
significant repression of high O2-induced Ngn3 
expression (P <0.05; Fig. 5D), showing that 
activated Wnt signaling is involved in facilitated 
differentiation in a high O2 condition. 
High oxygen condition facilitates 
differentiation of hiPSC into insulin-producing 
cells - We performed pancreatic differentiation 
from hiPSC clone 23 (25) by our stepwise 
protocol (Fig. 6A), and analyzed marker 
expression by immunofluorescence analysis. It 
was confirmed that the expression of SOX17, a 
definitive endoderm marker, was not detected in 
undifferentiated cells (ud), but was markedly 
expressed on day 7 (stage 1) during differentiation. 
That signal continued to appear on day 11 (stage 
2) to 17 (stage 3) (Fig. 6B). Another definitive 
endoderm marker, FOXA2, also began to be 
expressed at stage 1, and also appeared in later 
periods (Fig. 6C). PDX1 expression, a marker of 
pancreatic progenitors, was not detected in ud and 
stage 1 (data not shown), while some signals were 
detected at stage 2 with a peak signal at stage 3 
(Fig. 6D). NGN3, a marker of endocrine 
progenitors, was also not detected in ud and stage 
1 (data not shown), while robust signals were 
detected at stage 2 and continued to be expressed 
at stage 3 (Fig. 6E). At stage 3, the termination of 
this differentiation protocol, several insulin- and 
C-PEPTIDE-positive cells were detected (Fig. 6E). 
Next, we examined the expression dynamics of 
marker genes by qPCR analysis, and concurrently 
compared our expression dynamics with that of a 
previously reported protocol (32) (Fig. 7A). It was 
revealed that the expression dynamics of analyzed 
genes during differentiation by our protocol (3-
step protocol) was similar to that of pancreatic -
cell development (33,34). The D’Amour protocol 
consists of stage 1 to stage 5. Stage 1 guides 
pluripotent cells to definitive endoderm, stage 2 
and 3 to pancreatic progenitors, stage 4 to 
endocrine progenitors, and stage 5 to hormone-
expressing endocrine cells. By the D’Amour 
protocol, SOX17 and FOXA2 were expressed 
higher than in our protocol at stage 1 (Fig. 7A). In 
contrast, PDX1 gene expression was very high at 
stage 2 of our protocol, and was higher than in the 
D’Amour protocol. Moreover, robust increases of 
NGN3, NEUROD1, MAFA and INS expression 
were detected at the termination of our protocol 
(Fig. 7A). The percentages of PDX1-, NGN3-, 
and C-PEPTIDE-positive cells in the population 
of differentiated cells by our protocol were higher 
than those by the D’Amour protocol (Fig. 7B). 
Different protocols are usually used for mESC 
and hESC/iPSC, especially different lengths of 
time. Therefore, we examined the effect of altered 
culture times on pancreatic differentiation of 
hiPSC. A shorter timeframe decreased the 
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percentage of C-PEPTIDE-positive cells (P <0.05), 
while a longer time had no effect (Fig. 7C).  
Next we investigated whether the high O2 
condition has an effect on the pancreatic 
differentiation of hiPSC (Fig. 8A). The effect of 
the high O2 condition during differentiation 
showed a similar result to that of mESC. 
Immunofluorescence analysis revealed a 
significant increase of the percentage of C-
peptide-positive cells by the high O2 condition 
during stage 1 (P <0.05; Fig. 8B). It was 
confirmed that there was significant increase in 
INS gene expression (P <0.05; Fig. 8C). These 
effects were also observed in an other hiPSC line, 
201B7 (34) (P <0.05; Fig. 8D). We performed 
immunostaining for glucagon to determine 
whether differentiated cells are monohormonal or 
polyhormonal by our protocol. A few glucagon-
positive cells were observed in the differentiated 
cells treated with the high O2 condition (Fig. 8E). 
Moreover, co-expression with C-PEPTIDE 
appeared in a few cells, suggesting that some cells 
were polyhormonal for insulin and glucagon. 
High oxygen condition facilitates 
differentiation of hiPSC into endocrine 
progenitors - Corresponding with our results on 
mESC, we observed that NGN3 expression was 
significantly increased on day 7 by the high O2 
condition during stage 1, while VEGFA and HES1 
expression were significantly decreased (P 
<0.0000005 and P <0.000005, respectively; Fig. 9, 
A and B). Immunofluorescence analysis 
confirmed that the percentage of NGN3-positive 
cells was increased by this treatment (Fig. 9C). To 
further determine whether HIF-1 inhibition and 
Wnt signaling activation are involved in the case 
of hiPSC, we performed Western blot analysis of 
HIF-1 and microarray analysis of high O2-
treated hiPSCs. The high O2 condition repressed 
the HIF-1 protein level (Fig. 9D). By microarray 
analysis, many genes were found to be 
upregulated by the high O2 condition, as listed in 
supplementary Figure S2A. Some of these genes 
were determined as the Wnt receptor signaling 
pathway in the GO biological process 
(Supplementary Fig. S2B), suggesting that Wnt 
signaling was also activated in high O2-treated 
hiPSCs. In addition, Dkk-1 treatment weakened 
high O2-induced NGN3 expression (Fig. 9E). 
These results in hiPSC are similar to those 
observed in mouse ESC, thereby indicating that 
both human and mouse pluripotent cells follow a 
similar pathway in a high O2 condition.  
We tested whether the high O2 condition had an 
effect even in the D’Amour protocol and Nostro 
protocol (1) (Fig. 10A). Using this protocol, we 
also saw a significant increase in the percentage of 
C-PEPTIDE-positive cells by the high O2 
condition from day 1 to 4 (Stage 1; P <0.05) and 
also in the INS expression by high O2 condition 
from day 1 to 4 (Stage 1; P <0.05) and day 4 to 7 
(Stage 2; P <0.05) (Fig. 10, B and C). However, in 
the Nostro protocol, we did not observe any 
facilitative effect of the high O2 condition on the 
percentage of C-PEPTIDE-positive cells (Fig. 10, 




Insulin-secreting pancreatic -cells are 
essential regulators of the mammalian metabolism. 
The absence of functional -cells leads to 
hyperglycemia and diabetes, making patients 
dependent on exogenously supplied insulin. 
Recent insights into -cell development, 
combined with the discovery of pluripotent stem 
cells, have led to an unprecedented opportunity to 
generate new -cells for transplantation therapy 
and drug screening (36,37). It is important to 
mimic the in vivo developmental stages of 
pancreatic organogenesis in which cells are 
transitioned through mesendoderm, definitive 
endoderm, foregut endoderm, pancreatic 
progenitor, and the endocrine progenitor stage, 
until mature -cells are obtained from pluripotent 
stem cells (38). Oxygen tension, the partial 
pressure of oxygen, has been shown to regulate 
the stem cell function and embryonic development 
of several organs, including pancreas (9,10,15-23). 
In the present study, we demonstrated that a high 
O2 condition during the in vitro differentiation of 
ESC and iPSC has a facilitative effect on 
generating pancreatic progenitors and insulin-
producing cells. 
In our stepwise differentiation protocol, the 
cells transitioned through definitive endoderm, 
pancreatic progenitor, endocrine progenitor, and 
insulin-producing cells as revealed by qPCR 
analysis. Induction of Pdx1 and Ngn3 gene 
expressions appeared on day 7 (stage 1), showing 
that slight transition to pancreatic progenitors and 
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endocrine progenitors had already started during 
stage 1 (Fig. 1B). With this protocol, treatment 
with a high O2 condition during stage 1 (toward to 
definitive endoderm) increased differentiation 
efficiency into endocrine progenitors, and 
subsequent insulin-producing cells. This was 
demonstrated by a significant increase of Ngn3-
positive cells and Ngn3 gene expression (Fig. 3, B, 
E and F). Ngn3 is a basic helix-loop-helix 
transcription factor expressed in cell progenitors 
that is necessary to initiate the endocrine 
differentiation program in pancreatic development 
(39,40), and its gene expression is inversely 
regulated by HIF-1 (22). Down regulation of 
Notch signaling will yield cells that express Ngn3 
(41). Ngn3 gene expression and pancreatic 
endocrine development are tightly regulated by 
Hes1, which is an inhibitory bHLH factor 
activated by Notch signaling, and binds to the 
proximal promoter of Ngn3 and specifically 
blocks promoter activity (39,42). It has been 
shown that HIF-1 activates Notch-responsive 
promoters and increases the expression of Notch 
direct downstream genes, including Hes1 (11). 
During differentiation, HIF-1 signaling is 
moderately activated even in normoxic conditions, 
revealed by HIF-1 protein expression and 
increase of its target gene Vegfa, while a high O2 
condition marked repressed both expressions (Fig. 
4, B and C). Supporting our results, it is reported 
that HIF-1 signaling of cultured stem cells is 
activated during spontaneous differentiation even 
in normoxic conditions, showing a time-
dependent increase of Vegfa (43). A high O2 
condition might increase cellular O2 concentration 
and lead to inhibition of HIF-1 signaling. The 
high O2 condition significantly repressed Hes1 
gene expression on day 5 and 6 (Fig 4D). 
Consistent with previous reports, inhibition of 
HIF-1 signaling might lead to repression of Hes1 
expression and subsequent induction of Ngn3 
expression in a high O2 condition. Furthermore, 
HIF-1 inhibitor echinomycin had a similar effect 
to the high O2 condition (Fig 4F). These data 
indicate that inhibition of HIF-1 signaling is 
involved in the facilitative effect of the high O2 
condition on pancreatic differentiation. The high 
O2 condition had no effect on Sox17 gene 
expression and the number of immunoreactive 
cells (Fig. 3, B and C), suggesting that its 
treatment might affect transition from definitive 
endoderm to pancreatic progenitor or endocrine 
progenitor. This is supported by the result that its 
treatment did not increase Ngn3 expression in the 
undifferentiated state (Fig 3G). The high O2 
condition significantly decreased Oct4 gene 
expression (Fig. 3B). Oct4 gene expression is 
directly regulated by HIF-2, also a hypoxia-
dependent factor (12); therefore, it is considered 
that the high O2 condition might repress Oct4 
gene expression via HIF-2 inhibition. 
By microarray analysis, we found that the Wnt 
signaling pathway is activated in high O2 
condition-treated cells (Fig. 5B). Wnt inhibitor 
Dkk-1 partially repressed high O2 condition-
induced Ngn3 expression (Fig 5D). It is reported 
that hypoxia inhibits Wnt signaling via HIF-1 
competing with T-cell factor-4 (TCF-4) for direct 
binding to -catenin (44). The high O2 condition 
might inhibit HIF-1 signaling and compensatory 
Wnt signaling was activated. This is supported by 
the result that genes induced by the HIF-1 
inhibitor echinomycin are also involved in the 
Wnt signaling pathway (Fig. 5C). The canonical 
Wnt cascade has emerged as a critical regulator of 
self-renewal and pluripotency in stem cells 
(30,45-49). In contrast, it is also reported that 
Wnt/-catenin signaling promotes the 
differentiation, not self-renewal, of embryonic 
stem cells (1,32,50,51). Nostro et al. showed that 
Wnt signaling induce a posterior endoderm fate, 
the primed stage from definitive endoderm, and at 
optimal concentrations enhanced the development 
of pancreatic lineage cells (1). In this report, Wnt 
signaling did not affect the levels of PDX1, but 
did increase INS expression in hiPSC with Wnt3a 
treatment at the stage of definitive endoderm to 
pancreatic endoderm. This report is consistent 
with our results that a high O2 condition activates 
Wnt signaling and facilitates differentiation from 
definitive endoderm into pancreatic fate. In the 
developing embryo, a key step in the generation 
of endoderm-derived cell types is patterning the 
appropriate region of the gut tube along the 
anterior-posterior axis. Studies using different 
model systems have shown that in gastrulation, 
Wnt signaling is restricted to the posterior region 
of the embryo and, together with FGF signaling, 
is responsible for the induction of a posterior 
phenotype (52,53). Activated Wnt signaling by a 
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high O2 condition might function to promote the 
development of a posterior phenotype in mESC 
and hiPSC cultures. 
The high O2 condition also facilitates 
pancreatic differentiation of hiPSC. Our stepwise 
differentiation protocol generated insulin-
producing cells larger than the D’Amour protocol 
(32). However, in the case of SOX17 and FOXA2, 
a robust increase was observed in the D’Amour 
protocol (Fig. 7A), indicating that the induction of 
definitive endoderm was more efficient than our 
three-step protocol. This might have been due to 
the difference of the Activin A (ActA) 
concentration (D’Amour protocol, 100 ng/ml; our 
protocol, 10 ng/ml), because induction of 
definitive endoderm by ActA is reported to 
increase in a dose-dependent fashion (54-56). 
However, at stage 2 of our protocol, there was a 
marked increase in the expression of PDX1, 
greater than at stage 4 of the D’Amour protocol. 
Furthermore, NGN3, NEUROD1, MAFA and INS 
gene expressions were higher in our protocol, 
indicating that the induction of pancreatic fate 
from definitive endoderm in our protocol was 
more efficient than with the D’Amour protocol. 
Using this protocol, hiPSCs more efficiently 
differentiated into endocrine progenitors and 
insulin-producing cells in the high O2 condition 
during stage 1, similar to mESCs. The effect of 
the high O2 condition was also observed in the 
D’Amour protocol, but not in the Nostro protocol 
(1) (Fig. 10, A-E). Nostro et al. included VEGF 
during stage 1, probably to support endothelial 
development for pancreatic differentiation of 
hESC (1, 57). The high O2 condition repressed 
VEGF expression in our study (Fig. 9B), and a 
similar effect is expected to occur in the Nostro 
protocol. This effect may compete with the 
addition of VEGF. Therefore, the high O2 
condition seems to have no facilitative effect in 
the Nostro protocol. 
Insulin-producing cells obtained in our study 
did not secrete insulin by high-glucose stimulation 
(data not shown), and some cells were 
polyhormonal because co-expression of insulin 
and glucagon occured. During normal human 
embryogenesis, β -cells are not generated until 
~10 weeks after endoderm specification (58), 
while in hiPSC differentiation cultures, this 
typically occurs in 2 to 3 weeks (32). It is possible 
that pancreatic differentiation in human ESC/iPSC 
culture may be accelerated by rapid changing of 
the transcriptional network and/or epigenetic 
modifications by changing supplements (growth 
factor and inhibitors, etc). For proper -cells it 
may be necessary to change the extracellular 
environment and signal more precisely to mimic 
normal human embryogenesis. 
In the previous study, Shah et al. stated that the 
early mammalian embryo is located within the 
uterus, with a non-existent or immature 
cardiovascular system and blood supply but, 
despite this hypoxic environment, the embryo is 
still able to undergo rapid growth and 
organogenesis (21). Furthermore, they showed 
that the number of Ngn3-positive cells was not 
altered by hypoxia treatment in pancreatic 
explants, while the number of insulin-positive 
cells was decreased by hypoxia, implying that 
high oxygen may only be required at later stages 
during pancreatic differentiation, namely 
endocrine progenitor to -cell. However, in our 
study, the number of Ngn3-positive cells 
differentiated from mESCs and hiPSCs was 
increased by the high O2 condition (Fig. 3, E, F 
and Fig. 9C). There are some differences between 
the culture environments of dissociated mESCs 
and pancreatic explants. (1) HIF-1α levels seem 
to be different between mESC culture and 
pancreatic explants because of spatial and 
temporal patterns of cell-cell interactions. (2) 
Moreover, the external signals were different, as 
our study used chemically defined medium, 
whereas pancreatic explants were maintained in 
serum-containing medium. These differences 
seemed to have caused the discrepancy. 
A previous study modulated the O2 
environment for pancreatic differentiation (59). 
Cheng et al. used a 5% O2 environment for 
maintaining and differentiating human 
endodermal progenitor (EP) cells into -cells. 
However, they did not mention the reason for 
using a hypoxic environment and did not compare 
the effect on differentiation cultured under 
hypoxia with normoxia. In our study, a hypoxic 
condition (5% O2) during differentiation had no 
facilitative effect on the number of Ins1-GFP-
positive cells of mESCs. This discrepancy seems 
to have been particularly caused by the cell 
density during differentiation. In their studies, EP 
cells were plated in 12-well dishes at 3-4 x 10
5
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cells per well as dissociated at the start of 
differentiation, whereas in our study, hiPSCs were 
grown for 7 days as a colony before the start of 
differentiation. In the colony state, cells appeared 
to promote a hypoxic phenotype because HIF-1α 
is expressed at a detectable level even in normoxia 
(Fig. 9D). Therefore, in our case, the high O2 
condition rather than the hypoxic condition 
facilitated pancreatic differentiation. 
 
In conclusion, the present study showed that a 
high O2 condition during differentiation has 
facilitative effects on generating insulin-producing 
cells from mESCs and hiPSCs. This effect was 
due to the inhibition of Notch signaling and 
activation of Wnt signaling during definitive 
endoderm to pancreatic fate. We also found that 
HIF-1 inhibition during differentiation 
accelerated the generation of pancreatic lineages. 
These observations would provide an efficient 
method of utilizing patient-specific iPS cells for 
the treatment of diabetes. 
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FIGURE 1. Stepwise differentiation of mESCs into insulin-producing cells. A, Scheme of the stepwise 
differentiation protocol used to generate insulin-producing cells from mES ING112 cells. Act A, 
ActivinA; bFGF, basic FGF; CYC, KAAD-cyclopamine; RA, retinoic acid; NAM, nicotinamide; GLP-1, 
glucagon-like peptide; ITS, insulin-transferrin-selenium. B, The dynamics of Oct4, Sox17, Foxa2, Pdx1, 
Ngn3 and Ins1 gene expression, several key markers in pancreatic differentiation, were analyzed at 
different stages in normoxic conditions by qPCR. n = 8 each. ud, undifferentiated cells. 
 
FIGURE 2. Effect of high O2 condition on differentiation efficiency of mESCs. A, Scheme of the 
timeline of high O2 condition. B, Immunofluorescence for Ins1-GFP on day 17 of differentiation in 
ING112 cells treated with a high O2 condition during stage 1. Scale bars = 200 µm. C, Values are the 
percentage of Ins1-GFP-positive cells per well of the cells treated with high O2 condition (60% O2) during 
three different stages. *P <0.05 versus corresponding control. n = 8 each. D, Values are the percentage of 
Ins1-GFP-positive cells per well of the cells treated with hypoxic condition (5% O2) during three different 
stages. n = 20 each. E, Values are the percentage of C-peptide-positive cells per well of the cells treated 
with the high O2 condition (60% O2) during three different stages in mESC line SK7. *P <0.05 versus 
corresponding control. n = 6 each. F, Cell viability assay on the number of viable cells after treatment 
with the high O2 condition (60% O2) during day 1 to day 7 or day 3 to day 7. n = 6 each. G, Values are the 
percentage of Ins1-GFP-positive cells per well of the cells treated with the high O2 condition (40% O2) 
during stage 1. *P <0.05 versus corresponding control. n = 6 each.  
 
FIGURE 3. Effect of high O2 condition on differentiation markers. A, Scheme of the timeline of high 
O2 condition. B, Levels of Oct4, Sox17, Pdx1 and Ngn3 gene were analyzed at day 6 of differentiation in 
normoxia or high O2-treated ING112 cells by qPCR. **p<0.01 versus corresponding control. n = 4 each. 
C-E, Immunofluorescence for Sox17 on day 6 (C), Pdx1 on day 11 (D), and Ngn3 on day 6 or day 11 (E) 
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of differentiation in ING112 cells treated with high O2 condition during stage 1. Scale bars = 200 µm. F, 
Values are the percentage of Ngn3-positive cells per well at day 6 or day 11 in normoxia or high O2-
treated ING112 cells. **P <0.01 versus corresponding control. n = 4 each. G, Levels of Ngn3 gene were 
analyzed on undifferentiated ING112 cells treated with high O2 condition for 3 days by qPCR. Effect of 
high O2 condition on differentiating cells is shown as a positive control. *P <0.05 versus corresponding 
control. n = 4 each. 
 
FIGURE 4. Effect of high O2 condition on Notch signaling. A, Scheme of the timeline of high O2 
condition. B, Levels of HIF-1 and -actin (loading control) were analyzed on day 6 of differentiation in 
normoxia, high O2, or hypoxia (1% O2; positive control)-treated ING112 cells by immunoblotting. C-E, 
Levels of Vegfa (C), Hes1 (D) and Ngn3 (E) gene were analyzed on day 3, 4, 5 and 6 of differentiation in 
normoxia or high O2-treated ING112 cells by qPCR. *P <0.05 or **P <0.01 versus corresponding control. 
n = 8 each. F, Levels of Vegfa, Hes1 and Ngn3 genes were analyzed on day 6 of differentiation in DMSO 
or 1 nM echinomycin-treated ING112 cells by qPCR. *P <0.05 or **P <0.01 versus corresponding 
control. n = 3 each. 
 
FIGURE 5. Microarray analysis on genes induced by high O2 condition. A, Microarray analysis was 
performed on ING112 cells treated with high O2 condition during day 3 to 5 of differentiation using a 
TORAY 3D-gene oligo chip. The genes induced by high O2 condition are shown determined by global 
normalization after excluding genes of <100 intensity in the high O2 condition group. Genes increased 
over 8-fold in the ratio of high O2 to normoxia are listed. B, C, Pathway analysis was performed on 
upregulated genes in the high O2-treated (B) or echinomycin-treated (C) group using GenMapp/MAPP 
Finder software. D, Levels of Ngn3 gene were analyzed on day 6 of differentiation in normoxia or high 
O2-treated ING112 cells with or without Wnt signaling inhibitor Dkk-1 by qPCR. *P <0.05 versus 
corresponding control. n = 11 each. 
 
FIGURE 6. Stepwise differentiation of hiPSCs into insulin-producing cells. A, Scheme of the stepwise 
differentiation protocol used to generate insulin-producing cells from hiPS C23 cells. B-E, 
Immunofluorescence for SOX17 (B), FOXA2 (C), PDX1 (D), NGN3 (E), INSULIN (E) and C-PEPTIDE 
(E) at day 7 (stage 1), 11 (stage 2) or 17 (stage 3) of differentiation in C23 cells in normoxic condition. 
Scale bars = 200 µm. 
 
FIGURE 7. Dynamics of pancreatic differentiation marker genes. A, The dynamics of SOX17, FOXA2, 
PDX1, NGN3, NEUROD1, MAFA and INS gene expression were analyzed at different stages in normoxic 
conditions under the D’Amour protocol or our 3-step protocol by qPCR. n = 3 each. ud, undifferentiated; 
st, stage. B, Values are the percentage of PDX1-, NGN3-, or C-PEPTIDE-positive cells per well of the 
cells differentiated under the D’Amour protocol or our 3-step protocol. n = 3 each. C, Values are the 
percentage of C-PEPTIDE-positive cells per well of the cells differentiated under different timeframe of 
our 3-step protocol. *P <0.05 versus corresponding control. n = 4 each. d, day. 
 
FIGURE 8. Effect of high O2 condition on differentiation efficiency of hiPSCs. A, Scheme of the 
timeline of high O2 condition. B, Immunofluorescence for C-PEPTIDE on day 17 of differentiation in 
C23 cells treated with high O2 condition during stage 1. Scale bars = 200 µm. Right graph, values are the 
percentage of C-PEPTIDE-positive cells per well of the cells treated with high O2 condition during three 
different stages. *P <0.05 versus corresponding control. n = 11 each. C, Level of INS gene was analyzed 
at day 17 of differentiation in normoxia or high O2-treated C23 cells by qPCR. *P <0.05 versus 
corresponding control. n = 4 each. D, Values are the percentage of C-PEPTIDE-positive cells per well of 
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the cells treated with high O2 condition during three different stages in hiPSC line 201B7. *P <0.05 
versus corresponding control. n = 8 each. E, Immunofluorescence for C-PEPTIDE and glucagon on day 
17 of differentiation in C23 cells treated with high O2 condition during stage 1. Scale bars = 200 µm. 
 
FIGURE 9. Effect of high O2 condition on NGN3 gene expression of hiPS cells. A, Scheme of the 
timeline of high O2 condition. B, Levels of VEGFA, HES1 and NGN3 gene were analyzed at day 7 of 
differentiation in normoxia or high O2-treated C23 cells by qPCR. *P <0.05 or **P <0.01 versus 
corresponding control. n = 4 each. C, Immunofluorescence for NGN3 on day 11 of differentiation in C23 
cells treated with high O2 condition during stage 1. Scale bars = 200 µm. Right graph, values are the 
percentage of NGN3-positive cells per well of the cells treated with high O2 condition during stage 1. *P 
<0.05 versus corresponding control. n = 3 each. D, Levels of HIF-1 and -actin (loading control) were 
analyzed on day 6 of differentiation in normoxia, high O2, or hypoxia (1% O2; positive control)-treated 
C23 cells by immunoblotting. E, Levels of NGN3 gene were analyzed on day 6 of differentiation in 
normoxia or high O2-treated C23 cells with or without Wnt signaling inhibitor Dkk-1 by qPCR. n = 4 
each. 
 
FIGURE 10. Effect of high O2 condition on differentiation efficiency of hiPSCs in D’Amour and 
Nostro protocol. A, Scheme of the D’Amour differentiation protocol and the timeline of high O2 
condition. FBS, fetal bovine serum; Ex-4, exendin-4; HGF, hepatocyte growth factor; IGF1, insulin-like 
growth factor 1. B, Values are the percentage of C-PEPTIDE-positive cells per well of the cells treated 
with high O2 condition during three different stages. *P <0.05 versus corresponding control. n = 6 each.  
C, Levels of INS gene were analyzed on day 17 of differentiation in cells treated with high O2 condition 
during five different stages by qPCR. *P <0.05 versus corresponding control. n = 7 each.  D, Scheme of 
the Nostro differentiation protocol and the timeline of high O2 condition. E, Values are the percentage of 
C-PEPTIDE-positive cells per well of the cells treated with high O2 condition during three different stages. 
n = 3 each. 
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Table 1. Primers used in quantitative real-time PCR analysis. 	
Mouse
 Genes  Sequences (forward and reverse) Product (bp)
 Act  CCTCATGAAGATCCTGACCGA 192
 TTGCCAATAGTGATGACCTGG
 Oct4  GAGGAAGCCGACAACAATGAGAACCTTCAG 227
 TTCTGGCGCCGGTTACAGAACCATACTCGA
 Sox17  GAACAGTTGAGGGGCTACAC 322
 GTTTAGGGTTTCTTAGATGC
 Foxa2  TGGTCACTGGGGACAAGGGAA 289
 GCAACAACAGCAATAGAGAAC
 Pdx1  TCACTGGAGCAGGGAAGTCCT 264
 TTCCGCTGTGTAAGCACCTCC
 Ngn3  ACTGCAGCAGTGGTCGAGTAC 225
 AAGGGATGAGGCGCCATCCTA
 Ins1  CAGCCCTTAGTGACCAGCTA 348
 ATGCTGGTGCAGCACTGATC
 Vegfa  GCTACTGCCGTCCGATTGAGA 185
 AGGTTTGATCCGCATGATCTGC
 Hes1  TCAACACGACACCGGACAAACC 270
 GGTATTTCCCCAACACGCTCG
Human
 Genes  Sequences (forward and reverse)  Product (bp)
  ACT  CCTCATGAAGATCCTCACCGA 192
 TTGCCAATGGTGATGACCTGG
 SOX17  GCATGACTCCGGTGTGAATCT 103
 TCACACGTCAGGATAGTTGCAGT
 FOXA2  ATTGCTGGTCGTTTGTTGTG 187
 TACGTGTTCATGCCGTTCAT
 PDX1  CCTTTCCCATGGATGAAGTC 145
 GGAACTCCTTCTCCAGCTCTA
 NGN3  TTGCGCCGGTAGAAAGGATGAC 249
 TCAGTGCCAACTCGCTCTTAGG
 NEUROD1  CCCATGGTGGGTTGTCATATATTCA 200
 CCAGCATCACATCTCAAACAGCAC
 MAFA  TGCAGCAGCGGCACATTC 128
 CGCCAGCTTCTCGTATTTCTCCTTGT
 INS  GAGGCCATCAAGCAGATCAC 373
 GGCTGCGTCTAGTTGCAGTA
 VEGFA  CCCTGATGAGATCGAGTACAT 496
 CGGCTTGTCACATCTGCAAGT
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MAPP Name! Z Score! p-value!
1! Wnt signaling pathway! 3.433! 0.007!
2! Focal adhesion! 3.073! 0.002!
3! Pentose phosphate pathway! 2.796! 0.015!
4! Inflammatory response pathway! 2.776! 0.011!
5! FAS pathway and stress induction of HSP regulation! 2.616! 0.02!
6! Senescence and autophagy! 2.601! 0.017!
7! Fructose and mannose metabolism! 2.578! 0.021!
8! Retinol metabolism! 2.535! 0.014!
9! Hypertrophy model! 2.488! 0.032!
10! Hypothetical network for drug addiction! 2.485! 0.032!
C!
MAPP Name! Z Score! p-value!
1! Prostaglandin synthesis and regulation! 5.665! 0.000 !
2! Wnt signaling pathway! 4.776! 0.000 !
3! Wnt signaling pathway and pluripotency! 4.423! 0.000 !
4! Retinol metabolism! 4.092! 0.003 !
5! CAR RET metabolism! 3.784! 0.016 !
6! Eicosanoid synthesis! 3.581! 0.007 !
7! Styrene degradation! 3.033! 0.034 !
8! Prostaglandin and leukotriene metabolism! 2.834! 0.027 !
9! Inflammatory response pathway! 2.459! 0.044 !
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D’Amour protocol	 3-step protocol	
Figure 7	
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